share_log

Vibe Reports 2021 Financial Results

Vibe Reports 2021 Financial Results

VIBE報告2021年財務業績
newsfile ·  2022/05/03 05:33

2021 Highlights

2021年亮點

  • Dispensary sales were up 19.5% in 2021
  • Revenue was $29.29 million, compared to $24.24 million in 2020
  • Adjusted EBITDA was $2.31 million
  • Positive Operating Cash Flow of $219,427
  • Completed two equity financings raising gross proceeds of CAD $19.11 million
  • Commenced development of a 10-acre F40 zoned agricultural land site in Monterey County via a $5.1 million cash acquisition
  • Cash position of $9,098,475 at December 31, 2021
  • 藥房銷售額在2021年增長了19.5%
  • 收入為2929萬美元,而2020年為2424萬美元
  • 調整後的EBITDA為231萬美元
  • 正運營現金流為219,427美元
  • 完成兩次股權融資,總收益1911萬加元
  • 通過510萬美元的現金收購,開始開發蒙特利縣一塊10英畝的F40分區農地
  • 截至2021年12月31日的現金狀況為9,098,475美元

Sacramento, California--(Newsfile Corp. - May 2, 2022) - Vibe Growth Corporation (CSE: VIBE) (OTCQX: VIBEF) (the "Company" or "Vibe"), a vertically integrated California cannabis enterprise, is pleased to announce its financial results for the 2021 fiscal year. All financial information is provided in U.S. dollars unless otherwise indicated.

加利福尼亞州薩克拉門託-(Newsfile Corp.-2022年5月2日)-Vibe Growth Corporation(CSE:氛圍) (OTCQX:VIBEF)(“公司“或”氛圍“),一家垂直整合的加州大麻企業,高興地宣佈其2021財年的財務業績。除非另有説明,所有財務信息都以美元提供。

The Consolidated Financial Statements and Management Discussion and Analysis ("MD&A") for the year ended December 31, 2021, are available on the Company's SEDAR profile at and Vibe's website at .

截至2021年12月31日止年度的綜合財務報表及管理層討論及分析(“MD&A”)可於公司的SEDAR簡介及Vibe的網站查閲。

"Vibe managed to generate positive operating cash flow in 2021, with the financial results showing strong year-over-year growth despite a very challenging Q4 for all operators in California. These results represent steady execution even during a challenging operating environment in the California market. The year also saw substantial operating achievements combined with strategic investments in cultivation and retail dispensaries, positioning Vibe as a leader in a consolidating marketplace," commented Vibe CEO Mark Waldron.

Vibe首席執行官Mark Waldron評論説:“Vibe在2021年成功地產生了正的運營現金流,財務業績顯示出強勁的同比增長,儘管加州的所有運營商在第四季度都面臨着非常嚴峻的挑戰。即使在加州市場具有挑戰性的運營環境中,這些結果也代表着穩步的執行。這一年還看到了巨大的運營成就,加上對種植和零售藥房的戰略投資,使Vibe成為整合市場中的領導者,”Vibe首席執行官Mark Waldron評論道。

Waldron continued, "We are in a much stronger position in retail and cultivation operations, and 2022 macro conditions have improved compared to late 2021. In addition, asset acquisition opportunities have increased as some market participants do not have the balance sheets to compete effectively. Vibe's financial strength and strong management team is well-poised to allow for an expansion of Vibe's retail and sales channels in California.

Waldron繼續表示:“我們在零售和種植業務方面處於更有利的地位,與2021年末相比,2022年的宏觀狀況有所改善。此外,由於一些市場參與者沒有有效競爭的資產負債表,資產收購機會增加。Vibe的財務實力和強大的管理團隊已做好準備,可以擴大Vibe在加州的零售和銷售渠道。

"It continues to be a great cannabis market for excellent operators, and Vibe's strategy has always been to exercise fiscal prudence and focus on the three key pillars that underpin our growth plan; vertical integration, cultivation expansion, and retail sales. While we eagerly await our final approvals and opening of our Salinas dispensary in June, our cultivation expansion initiatives at our Sacramento and Monterey County properties continue to progress on schedule and under budget. Growing our retail dispensary locations and expanding our cultivation footprint will provide Vibe significant economies of scale and the ability to improve margins significantly, optimizing return on capital for Vibe shareholders," added Waldron.

對於優秀的運營商來説,這仍然是一個巨大的大麻市場,Vibe的戰略一直是謹慎理財,專注於支撐我們增長計劃的三大支柱:垂直整合、種植擴張和零售銷售。雖然我們熱切地等待我們的Salinas藥房的最終批准並於6月份開業,但我們在薩克拉門託和蒙特利縣的種植擴張計劃繼續按計劃進行,並在預算範圍內。發展我們的零售藥房地點和擴大我們的種植足跡將為Vibe提供顯著的規模經濟和顯著提高利潤率的能力,優化Vibe股東的資本回報率。

Fourth Quarter 2021 Highlights:

2021年第四季度亮點:

  • Revenue in the fourth quarter was USD $6.32 million, compared to USD $7.05 million recorded in the fourth quarter of 2020;
  • Adjusted EBITDA in the fourth quarter was USD $0.01 million, compared to USD $0.84 million recorded during the fourth quarter of 2020(1);
  • Dispensary Gross Margin increased to 41.6%, compared to 35.5% in the fourth quarter of 2020(1);
  • Dispensary Sales decreased 11.1% compared to the fourth quarter of 2020;
  • E-commerce Orders accounted for 22.3% of transactions in the fourth quarter of 2021;
  • Equity Financing of USD $3.52 million was completed in December.
  • Cash Position as of December 31, 2021, was USD $9,098,475.
  • 收入第四季度為632萬美元,而2020年第四季度為705萬美元;
  • 調整後的EBITDA第四季度為10萬美元,而2020年第四季度為84萬美元(1);
  • 藥房毛利率增至41.6%,而2020年第四季度為35.5%(1);
  • 藥房銷售與2020年第四季度相比下降11.1%;
  • 電子商務訂單佔2021年第四季度交易額的22.3%;
  • 股權融資352萬美元已於12月完成.
  • 現金頭寸截至2021年12月31日,為9,098,475美元。

(1) This is a non-IFRS measure. Readers are cautioned that the amounts presented do not have standardized meanings prescribed by IFRS. Please see the non-GAAP Financial Measures Disclosure below.

(1)這是一項非國際財務報告準則的措施。請讀者注意,列報的金額沒有國際財務報告準則所規定的標準含義。請參閲下面的非公認會計準則財務指標披露。

2021 Financial Highlights:

2021年財務亮點:

The following table reconciles the net loss, EBITDA, Adjusted EBITDA and operating cash flow:

下表對淨虧損、EBITDA、調整後EBITDA和營業現金流進行了核對:

The Company's key financial results for the three and twelve months ended December 31, 2021, and 2020 are as follows:

公司截至2021年12月31日和2020年12月31日的三個月和十二個月的主要財務業績如下:

U.S. Dollars For the three months ended December 31, 2021 For the three months ended
December 31, 2020
For the year
ended December 31, 2021
For the year
ended December 31, 2020
Total revenue(a) $6,315,811 $7,048,294 $29,287,569 $24,240,862
Gross margin $1,453,206 $2,716,669 $8,421,564 $8,540,496
Adjusted Gross Margin(b) 1,621,139 $2,634,677 $9,138,973 $5,559,381
Adjusted Gross Margin(b) 25.7% 37.4% 31.2% 33.8%
Net income (loss) $(3,340,001) $188,359 $(4,298,739) $728,550
Adjusted EBITDA(a) $73,125 $842,364 $2,308,864 $2,965,075
美元 截至2021年12月31日的三個月 截至以下三個月
2020年12月31日
這一年的
截至2021年12月31日
這一年的
截至2020年12月31日
總收入(a) $6,315,811 $7,048,294 $29,287,569 $24,240,862
毛利率 $1,453,206 $2,716,669 $8,421,564 $8,540,496
調整後的毛利率(b) 1,621,139 $2,634,677 $9,138,973 $5,559,381
調整後的毛利率(b) 25.7% 37.4% 31.2% 33.8%
淨收益(虧損) $(3,340,001) $188,359 $(4,298,739) $728,550
調整後的EBITDA(a) $73,125 $842,364 $2,308,864 $2,965,075

Special Note Regarding non-GAAP Financial Measures

關於非公認會計準則財務指標的特別説明

  1. This is a non-GAAP measure. Readers are cautioned that the amounts presented do not have standardized meanings prescribed by IFRS. See discussion of non-IFRS Measures in the MD&A for reconciliation to measures reported in the Company's consolidated financial statements.
  2. Excludes changes in the fair value of biological assets.
  3. Operating Cash Flow is a non-GAAP measure that represents cash flows from normalized operating activities. The Company considers operating cash flow a key measure as it demonstrates the Company's ability to generate the cash flow necessary to fund future growth through capital investment and to repay debt.
  1. 這是一項非公認會計準則的衡量標準。請讀者注意,列報的金額沒有國際財務報告準則所規定的標準含義。請參閲MD&A中關於非IFRS措施的討論,以與公司合併財務報表中報告的措施進行對賬。
  2. 不包括生物資產公允價值的變動。
  3. 營業現金流是一種非公認會計準則計量,代表標準化經營活動的現金流。公司認為運營現金流是一項關鍵指標,因為它表明公司有能力通過資本投資產生必要的現金流,為未來的增長提供資金,並償還債務。

Additional Fourth Quarter Highlights:

第四季度的其他亮點:

  • Vibe Growth Corporation Uplists to OTCQX Best Market (October 5, 2021)
    Effective October 5, its common shares have been approved for trading under the ticker symbol "VIBEF" on the OTCQX® Best Market (the "OTCQX"), a U.S. trading platform operated by the OTC Markets Group, Inc. "The OTCQX Market provides Vibe access to a much larger audience of U.S.-based institutional and retail investors and complements our CSE listing by providing investors with direct access to our common shares in both countries. Canadian and U.S. institutional and retail investors can take an active part in the exciting growth that California cannabis offers," Waldron added. Vibe Growth continues to trade on the Canadian Securities Exchange ("CSE") under its existing symbol "VIBE". Read Full Release

  • Vibe Growth Announces Closing of Strategic Investment of C$3.52 Million in a Non-Brokered Private Placement of Common Shares (December 22, 2021)
    A strategic investor in Vibe Growth Corp. is investing $3.52-million in a non-brokered private placement of common shares. Mark Waldron, chief executive officer of Vibe, stated, "We are extremely pleased to welcome this strategic shareholder in Vibe. The investment demonstrates confidence in our team's ability to execute on our growth and expansion strategy -- growing our retail dispensary locations and expanding our cultivation footprint, which will provide Vibe significant economies of scale and the ability to improve margins and optimize return on capital for Vibe shareholders." Read Full Release

  • Vibe Growth Corporation榮登OTCQX最佳市場(2021年10月5日)
    自10月5日起,其普通股已獲準在OTCQX以“VIBEF”為股票代碼進行交易®OTC Markets Group,Inc.運營的美國交易平臺Best Market(“OTCQX”)。Waldron補充説:“OTCQX市場為Vibe提供了接觸更多美國機構和散户投資者的渠道,並通過讓投資者直接進入我們在兩個國家的普通股來補充我們的CSE上市。加拿大和美國的機構和散户投資者可以積極參與加州大麻提供的令人興奮的增長。”Vibe Growth繼續在加拿大證券交易所(“CSE”)交易,現有代碼為“VIBE”。閲讀完整版本

  • Vibe Growth宣佈完成非經紀私募普通股的352萬加元戰略投資(2021年12月22日)
    Vibe Growth Corp.的一位戰略投資者將投資352萬美元進行非經紀私募普通股。 Vibe首席執行官馬克·沃爾德隆表示:“我們非常高興地歡迎Vibe的這一戰略股東。這筆投資表明了我們對我們團隊執行我們的增長和擴張戰略的能力的信心--擴大我們的零售藥房地點和擴大我們的種植足跡,這將為Vibe提供顯著的規模經濟,並有能力為Vibe股東提高利潤率和優化資本回報率。”閲讀完整版本

Events Subsequent to December 31, 2021:

2021年12月31日之後的事件:

  • Vibe Growth Corporation Announces Expansion of California Dispensary Portfolio (February 8, 2022)
    Vibe Growth Corp. has received provisional approval from the California Department of Cannabis Control to commence adult-use retail sales at its newest dispensary location in Salinas, California. Read Full Release

  • Vibe Further Expands its California Dispensary Portfolio, receiving a State license to open its seventh dispensary location in Ukiah, California (February 22, 2022)
    Vibe received its license from the DCC under its subsidiary - Vibe Ukiah LLC, for adult-use sales in its dispensary located at 441 State Street N, conveniently located in the heart of Ukiah's vibrant downtown core. The new Vibe By California branded Ukiah dispensary is scheduled to open on March 4thand offers exceptional foot traffic access and visibility from the city's bustling downtown core. The Ukiah dispensary will provide consumers across the Mendocino Valley with a wide selection of leading cannabis brands and products. Read Full Release

  • Vibe's newest dispensary, located in Ukiah, California, opens its doors to the public (March 10, 2022)
    The Ukiah store hours are from 9 am to 9 pm and will provide residents and visitors to the Mendocino Valley with a wide selection of leading cannabis brands and products. Vibe's Ukiah dispensary will offer a curated product assortment featuring top-tier California brands and the Company's Hype Cannabis Co. marijuana product lineup. Online ordering with same-day express pickup is available at . Mark Waldron, CEO of Vibe stated, "We are thrilled to be opening our doors to the Ukiah community, and we look forward to providing our customers with the largest selection of premium cannabis products and a wonderful retail experience." Read Full Release

  • Vibe Growth Corporation宣佈擴大加州藥房投資組合(2022年2月8日)
    VIBE Growth Corp.已獲得加州大麻控制部門的臨時批准,將在其位於加利福尼亞州薩利納斯的最新藥房開始成人用途零售。閲讀完整版本

  • VIBE進一步擴大了其加州藥房組合,獲得了在加利福尼亞州尤凱亞開設第七家藥房的州許可證(2022年2月22日)
    Vibe在其子公司Vibe Ukiah LLC下獲得了DCC的許可證,在其位於道富N街441號的藥房進行成人銷售,該藥房位於Ukiah充滿活力的市中心的中心,位置便利。新的Vibe by California品牌Ukiah藥房計劃於3月4日開業這是並提供出眾的步行交通通道和從城市繁華的市中心的可見度。Ukiah藥房將為門多西諾山谷的消費者提供廣泛的領先大麻品牌和產品選擇。閲讀完整版本

  • Vibe位於加利福尼亞州尤凱亞的最新藥房向公眾開放(2022年3月10日)
    Ukiah商店的營業時間為上午9點至晚上9點,將為門多西諾山谷的居民和遊客提供廣泛的領先大麻品牌和產品選擇。Vibe的Ukiah藥房將提供精心策劃的產品類別,以加州頂級品牌和該公司大肆宣傳的大麻產品陣容為特色。網上訂購即日特快專遞,地址:。Vibe的首席執行官Mark Waldron説:“我們很高興能夠向Ukiah社區敞開大門,我們期待着為我們的客户提供最多的優質大麻產品選擇和美妙的零售體驗。”閲讀完整版本

About Vibe Growth Corporation

關於Vibe Growth公司

Vibe Growth Corporation and its cannabis retail brand, Vibe By California, is a trusted, vertically integrated cannabis enterprise with retail dispensaries; cannabis greenhouse cultivation; premium indoor cultivation; commercial cannabis distribution; brand sales and marketing; e-commerce platform; home delivery; and Hype Cannabis Co. marijuana and Vibe CBD (cannabidiol) products. Vibe is focused on maximizing shareholder value through accelerating organic growth, opportunistic acquisitions, distressed workouts, and new license applications. The Company operates retail and e-commerce under its iconic Vibe By California brand.

Vibe Growth Corporation及其大麻零售品牌Vibe by California是一家值得信賴的垂直一體化大麻企業,擁有大麻藥房、大麻温室種植、優質室內種植、商業大麻分銷、品牌銷售和營銷、電子商務平臺、送貨上門以及炒作大麻公司大麻和Vibe CBD(大麻二醇)產品。Vibe專注於通過加速有機增長、機會性收購、陷入困境的鍛鍊和新的許可證申請來實現股東價值最大化。該公司以其標誌性的Vibe by California品牌經營零售和電子商務。

To learn more about Vibe, please visit:

要了解有關Vibe的更多信息,請訪問:

Company Contact

公司聯繫人

Bill Mitoulas
Investor Relations
Phone: +1 416.479.9547
Email: ir@vibebycalifornia.com
Website:

比爾·米圖拉斯
投資者關係
電話:+1 416.479.9547
電子郵件:ir@vibebyCalifornia.com
網站:

Forward-Looking Information

前瞻性信息

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "anticipate", "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events, and may be impacted as a result of general economic conditions or the ongoing COVID-19 pandemic. Actual future results may differ materially.

本新聞稿中包含的某些陳述屬於前瞻性信息。這些陳述與未來的事件或未來的表現有關。使用“預期”、“可能”、“打算”、“預期”、“相信”、“將”、“預計”、“估計”以及與非歷史事實有關的類似表述和陳述,旨在識別前瞻性信息,基於各方目前對此類未來事件的結果和時間的看法或假設,並可能受到一般經濟狀況或持續的新冠肺炎疫情的影響。未來的實際結果可能會有很大不同。

The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. Risk factors related to the Company are described in the Company's Management Discussion and Analysis, a copy of which is available under the Company's profile on SEDAR.

本新聞稿中包含的前瞻性信息是截至本文發佈之日的,除非適用的證券法要求,否則雙方沒有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因。由於本文包含的風險、不確定性和假設,投資者不應過度依賴前瞻性信息。上述陳述明確表示,本文中包含的任何前瞻性信息都是合格的。與公司相關的風險因素在公司管理層討論和分析中進行了描述,其副本可在SEDAR上的公司簡介下獲得。

This press release includes market and industry data that has been obtained from third party sources, including industry publications. The Company believes that the industry data is accurate and that its estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there is no assurance as to the accuracy or completeness of included information. Although the data is believed to be reliable, the Company has not independently verified any of the data from third party sources referred to in this press release or ascertained the underlying economic assumptions relied upon by such sources.

本新聞稿包括從包括行業出版物在內的第三方來源獲得的市場和行業數據。本公司相信行業數據是準確的,其估計和假設是合理的,但不能保證這些數據的準確性或完整性。第三方消息來源一般聲明,其中包含的信息是從被認為可靠的來源獲得的,但不能保證所包括信息的準確性或完整性。儘管這些數據被認為是可靠的,但本公司尚未獨立核實本新聞稿中提及的任何第三方來源的數據,也沒有確定這些來源所依賴的基本經濟假設。

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any State securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable State securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities laws.

本新聞稿不構成在美國出售或邀請購買任何證券的要約。這些證券沒有也不會根據修訂後的《1933年美國證券法》(以下簡稱《美國證券法》)或任何州證券法進行登記,除非根據《美國證券法》和適用的州證券法登記或獲得此類登記豁免,否則不得在美國境內或向美國公民發行或出售證券。不得分發給美國新聞通訊社或在美國境內傳播。任何不遵守這一限制的行為都可能構成對美國證券法的違反。

Unlike in Canada which has Federal legislation uniformly governing the cultivation, distribution, sale and possession of medical cannabis under the Cannabis Act (Federal), readers are cautioned that in the U.S., cannabis is largely regulated at the State level. To the knowledge of Vibe Growth Corporation, there are to date a total of 35 states, plus the District of Columbia, that have legalized cannabis in some form. Notwithstanding the permissive regulatory environment of medical cannabis at the State level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S. and as such, cannabis-related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. Federal law. Strict compliance with State laws with respect to cannabis will neither absolve Vibe Growth Corporation of liability under the U.S. Federal law nor will it provide a defence to any Federal proceeding, which may be brought against Vibe Growth Corporation. Any such proceedings brought against Vibe Growth Corporation may adversely affect its operations and financial performance.

與加拿大不同的是,加拿大的聯邦立法根據《大麻法案》(Federal)統一管理醫用大麻的種植、分銷、銷售和擁有,讀者需要注意的是,在美國,大麻在很大程度上是由州一級監管的。據Vibe Growth Corporation瞭解,到目前為止,總共有35個州,加上哥倫比亞特區,以某種形式將大麻合法化。儘管在州一級對醫用大麻實行寬鬆的監管環境,但根據美國《受控物質法》,大麻仍被歸類為受控物質,因此,根據美國聯邦法律,與大麻有關的做法或活動,包括但不限於製造、進口、擁有、使用或分銷大麻,都是非法的。嚴格遵守有關大麻的州法律既不能免除Vibe Growth Corporation在美國聯邦法律下的責任,也不能為可能對Vibe Growth Corporation提起的任何聯邦訴訟提供辯護。對Vibe Growth Corporation提起的任何此類訴訟都可能對其運營和財務業績產生不利影響。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論